Survodutide 10mg

Description

🧬 Buy Survodutide 10 mg Peptide Online in the EU | High-Purity Research Grade

Buy Survodutide 10 mg peptide in the European Union from LeoLab™, a trusted supplier of high-purity, research-grade peptides for advanced metabolic and endocrine research.
Survodutide (BI 456906) is a dual GLP-1 and glucagon receptor agonist peptide, developed to study the interconnected pathways of energy balance, lipid metabolism, and glucose regulation.

By co-activating both GLP-1 (Glucagon-Like Peptide-1) and glucagon receptors, Survodutide offers a cutting-edge model for exploring multi-hormonal regulation of metabolism, making it a key research compound in the study of obesity, diabetes, and energy homeostasis.

Each batch is ≥99% pure, verified by HPLC and Mass Spectrometry, and produced under strict EU laboratory standards to ensure reproducibility, purity, and performance.

🔬 Key Features of Survodutide Peptide for Sale

• Purity: Verified ≥99% purity by HPLC and MS.

• Form: Lyophilized (freeze-dried) peptide powder for research use only.

• Molecular Formula: C₂₄₆H₃₉₆N₆₂O₇₅

• Mechanism: Dual GLP-1/glucagon receptor agonist promoting glucose balance, energy expenditure, and fat oxidation.

• Storage: Store between 2°C and 8°C (36–46°F), protected from light and moisture. After reconstitution, refrigerate and avoid repeated freeze–thaw cycles.

⚗️ Scientific Overview: Mechanism & Research Applications

Mechanism of Action

Survodutide (BI 456906) is a dual-agonist peptide that activates both GLP-1 and glucagon receptors—two key hormonal targets in energy metabolism and glycemic control.

Mechanistic Summary:

• GLP-1 Receptor Activation: Enhances insulin secretion, slows gastric emptying, and reduces appetite through central nervous system pathways.

• Glucagon Receptor Activation: Promotes hepatic fat oxidation and increases basal metabolic rate, supporting studies of energy expenditure.

• Dual Activation: Creates a synergistic effect on glucose regulation and fat utilization, offering an innovative model for obesity and metabolic disease research.

Key Research Findings

• Enhanced Energy Expenditure: Promotes thermogenesis and fat oxidation in animal and in vitro models.

• Improved Glycemic Control: Stimulates insulin secretion while lowering fasting glucose levels.

• Lipid Metabolism: Reduces hepatic fat accumulation and improves lipid profiles.

• Appetite Regulation: Demonstrates reduced food intake via hypothalamic signaling.

• Cardiometabolic Research: Potential application in studies addressing dyslipidemia and metabolic syndrome.

🧪 Research Applications

Survodutide 10 mg is studied in:

• Obesity and weight management models

• Type 2 diabetes and insulin resistance research

• Lipid metabolism and energy expenditure studies

• Hormonal receptor signaling and cross-talk

• Cardiometabolic and endocrine physiology

Its dual mechanism makes it a next-generation tool for exploring multi-receptor metabolic regulation and energy balance at both systemic and cellular levels.

📦 What’s Included

• 1 × Survodutide 10 mg vial (lyophilized peptide powder)

• 1 × 3 mL bacteriostatic water vial

• 1 × mixing syringe

• 4 × insulin syringes

• 4 × alcohol wipes

• Certificate of Analysis (COA) and Safety Data Sheet (SDS) verifying purity and identity

🌍 Why Choose LeoLab™ – Europe’s Trusted Peptide Supplier

• EU-Certified Quality: Each batch independently verified for ≥99% purity and stability.

• Fast, Reliable EU Shipping: Temperature-controlled logistics across all EU member states.

• Trusted by Researchers: Used by universities, biotechnology institutes, and pharmacology labs.

• Comprehensive Documentation: Each order includes COA and SDS for transparency and compliance.

🧬 Order Survodutide 10 mg Peptide Online in the EU

Advance your metabolic and endocrine research with Survodutide 10 mg from LeoLab™ Europe — a dual GLP-1 and glucagon receptor agonist peptide that offers a breakthrough model for studying fat oxidation, insulin regulation, and energy metabolism.